During the past decade, Capital Health Medical Center-Hopewell conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 11 clinical trials were completed, i.e. on average, 47.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Health Medical Center-Hopewell" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "NRG Oncology" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Health Medical Center-Hopewell" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Capital Health Medical Center-Hopewell" are "Breast Adenocarcinoma" (3 trials), "Breast Cancer" (3 trials), "Stage IB Breast Cancer" (3 trials), "Stage II Breast Cancer" (3 trials) and "Breast Carcinoma" (2 trials). Many other conditions were trialed in "Capital Health Medical Center-Hopewell" in a lesser frequency.

Most popular intervention types in "Capital Health Medical Center-Hopewell" are "Drug" (23 trials), "Other" (19 trials), "Radiation" (17 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (10 trials), "Laboratory Biomarker Analysis" (9 trials), "Questionnaire Administration" (6 trials), "Radiation Therapy" (6 trials) and "Magnetic Resonance Imaging" (5 trials). Other intervention names were less common.

The vast majority of trials in "Capital Health Medical Center-Hopewell" are 25 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Capital Health Medical Center-Hopewell". undefined are not yet recruiting, 15 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Capital Health Medical Center-Hopewell, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Health Medical Center-Hopewell, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Capital Health Medical Center-Hopewell has several departments that took part in Clinical trials: "Capital Health System Regional Cancer Center" - 9 trials, "Premier Urology Associates" - 7 trials, "Mercer Bucks Oncology-Hematology" - 2 trials